This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos HA, Meyers SN, Benzuly KH, Flaherty JD, Ricciardi MJ, Bennett CL, Williams DO.Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA: the Journal of the American Medical Association 297: 1992-2000, No. 18, 9 May 2007
Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, Granada JF, Marulkar S, Nassif D, Cohen DJ, Kleiman NS, Event Registry Investigators.Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA: the Journal of the American Medical Association 297: 2001-2009, No. 18, 9 May 2007
Harrington RA, Ohman EM.The enigma of drug-eluting stents: hope, hype, humility, and advancing patient care. JAMA: the Journal of the American Medical Association 297: 2028-2030, No. 18, 9 May 2007
Rights and permissions
About this article
Cite this article
Off-label or untested use of drug-eluting stents warranted?. Pharmacoecon. Outcomes News 528, 5 (2007). https://doi.org/10.2165/00151234-200705280-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705280-00006